Synthetic cannabinoids cause far more severe and unpredictable toxicities than marijuana

A review of synthetic cannabinoid toxicities found severe effects across multiple organ systems, including cardiac arrest, psychosis, seizures, kidney failure, and deaths from products tainted with rat poison.

Alipour, Azita et al.·The mental health clinician·2019·Moderate EvidenceReview
RTHC-01906ReviewModerate Evidence2019RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Synthetic cannabinoids produced a wide range of severe toxicities including arrhythmias, myocardial infarction, sudden cardiac death, psychosis, suicidal ideation, seizures, acute tubular necrosis, and intracranial hemorrhage. An outbreak of coagulopathies linked to brodifacoum-contaminated products caused at least 4 deaths.

Key Numbers

At least 4 deaths from brodifacoum-contaminated synthetic cannabinoids. Toxicities affected cardiovascular, neurological, renal, and hematological systems. Products are not detected on routine drug screens.

How They Did This

Literature review searching PubMed and SciFinder databases for reports on synthetic cannabinoid toxicities, limited to human studies in English.

Why This Research Matters

Synthetic cannabinoids are marketed as safe marijuana alternatives, but they are far more potent at cannabinoid receptors and produce unpredictable, sometimes fatal toxicities. Their constantly changing chemical compositions and absence from standard drug tests make them particularly dangerous.

The Bigger Picture

The synthetic cannabinoid problem is a moving target. New compounds appear faster than they can be studied or regulated. The toxicity profile is fundamentally different from natural cannabis, making the "synthetic marijuana" label dangerously misleading.

What This Study Doesn't Tell Us

The review relied on published case reports and case series, which may overrepresent severe outcomes. The constantly changing composition of synthetic cannabinoids means findings may not apply to newer formulations.

Questions This Raises

  • ?How can emergency departments better detect synthetic cannabinoid exposure?
  • ?Are there common mechanisms underlying the diverse organ toxicities?
  • ?Would expanded cannabis legalization reduce synthetic cannabinoid use?

Trust & Context

Key Stat:
At least 4 deaths from contamination
Evidence Grade:
Rated moderate because the review synthesizes multiple human case reports and series, though the evidence is observational rather than experimental.
Study Age:
Published in 2019. The synthetic cannabinoid landscape continues to evolve with new compounds appearing regularly.
Original Title:
Review of the many faces of synthetic cannabinoid toxicities.
Published In:
The mental health clinician, 9(2), 93-99 (2019)
Database ID:
RTHC-01906

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

Are synthetic cannabinoids safer than marijuana?

No. This review documented far more severe toxicities from synthetic cannabinoids than are typically associated with natural cannabis, including cardiac arrest, kidney failure, and deaths. They are more potent and unpredictable.

Do drug tests detect synthetic cannabinoids?

Standard drug tests generally do not detect synthetic cannabinoids, which is one reason some users choose them. This also makes it harder for emergency physicians to identify exposure.

Why did some synthetic cannabinoids cause bleeding?

An outbreak of coagulopathy was caused by products contaminated with brodifacoum, a chemical used in rat poison. This illustrates how unregulated manufacturing introduces additional dangers beyond the drugs themselves.

Read More on RethinkTHC

Cite This Study

RTHC-01906·https://rethinkthc.com/research/RTHC-01906

APA

Alipour, Azita; Patel, Puja Baldev; Shabbir, Zaheera; Gabrielson, Stephen. (2019). Review of the many faces of synthetic cannabinoid toxicities.. The mental health clinician, 9(2), 93-99. https://doi.org/10.9740/mhc.2019.03.093

MLA

Alipour, Azita, et al. "Review of the many faces of synthetic cannabinoid toxicities.." The mental health clinician, 2019. https://doi.org/10.9740/mhc.2019.03.093

RethinkTHC

RethinkTHC Research Database. "Review of the many faces of synthetic cannabinoid toxicities..." RTHC-01906. Retrieved from https://rethinkthc.com/research/alipour-2019-review-of-the-many

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.